In sporadic JMML, pathogenic SHP2 variants affect specific residues in exon 3 and 13, increasing the activity of SHP2 in the same way as NS mutations (Tartaglia et al., 2003). The gene discussed is PTPN11; the disease is juvenile myelomonocytic leukemia.